Fresenius Medical Care
- Market cap
- 11.01B
- P/E (TTM)i
- 11.14
- P/Bi
- 0.78
- EPSi
- 1.88
- Div yieldi
- 4.13%
- 52W posi
- 20%
Anonymous reader poll. Unscientific, not investment advice.
About Fresenius Medical Care
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
- Founded
- 2006
- CEO
- Ms. Helen Giza
- Employees
- 109,698
- Headquarters
- Bad Homburg, Hessen, Germany
- Fiscal year end
- 12-31
- Website
- freseniusmedicalcare.com/de
Company profile
- Exchange
- US
- Symbol
- FMS
- Market-cap rank
- #1333
- Listing date
- 1970-01-01
- Market cap
- 11.01B
- Float cap
- 8.23B
- Shares out
- 532.22M
- Float shares
- 397.66M
Sectors & themes
Quote time 2026-10-08 08:01:18 · For reference only, not investment advice and not tailored to your situation.